ÂÜÀòÂÒÂ×

Satabdi Chatterjee, PhD, MS, is an experienced professional in health economics and outcomes research (HEOR), currently serving as Product Director at Boehringer Ingelheim, leading the US HEOR team for the Pipeline Cardio Renal Metabolic division. Previously, Satabdi held the position of Associate Director for US HEOR with a focus on chronic kidney disease at Boehringer Ingelheim. Prior experience includes managerial roles in global pricing and market access as well as global HEOR at Novartis. Satabdi also worked as a Research Lead and Co-investigator on funded grants at the University of Houston and served as a Teaching/Research Assistant at the University of Houston College of Pharmacy. Educational qualifications include a BS in Pharmacy (Hons) from Jadavpur University and an MS and PhD from the University of Houston.